Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAUMOX2: Restrictive vs Liberal Oxygen in Trauma
NCT05146700Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2021
- Primary completion
- Oct 2023
- Modality
- Inhalation Devices
- Countries
- 3
01
Overview
Phase 4, randomised, open-label trial of oxygen in wounds and injuries, sponsored by Rigshospitalet. Primary endpoint: Incidence of 30-day mortality and/or major respiratory complications (pneumonia and acute respiratory distress syndrome) within 30 days. Started Dec 2021; status: completed.
02
Drugs
oxygen
03
Conditions
wounds and injuries
Beyond the preview
Go deeper on NCT05146700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05146700.